Terug
Dagbereik
€ 22,42
€ 23,87
52-Weeksbereik
€ 10,44
€ 47,65
Volume
784.570
50D / 200D Gem.
€ 29,55
/
€ 29,16
Vorige Slotkoers
€ 23,65
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,8 | 0,3 |
| P/B | 2,4 | 2,9 |
| ROE % | -36,9 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 46,00
+101.0%
Low: € 30,00
High: € 56,00
Forward WPA
-€ 2,19
Omzet Sch.
560000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,23
€ 2,67 – € 13,20
|
1,3 B | 1 |
| FY2029 |
€ 2,48
€ 1,26 – € 6,25
|
750 M | 1 |
| FY2028 |
-€ 0,94
-€ 1,58 – -€ 0,28
|
250 M | 5 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -142,43M
PEG of 0,42 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-36,91%
ROIC-19,79%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio43,76
Interest Coverage0,00
Waardering
P/E Ratio
-9,81
P/B Ratio2,35
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -154,65M |
| ROE | -36,91% | ROA | -23,37% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -142,43M |
| ROIC | -19,79% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 43,76 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,81 | P/B Ratio | 2,35 |
| P/S Ratio | N/A | PEG Ratio | 0,42 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,52B | Enterprise Value | 1,34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -154,65M | -177,81M | -71,90M | -29,80M | -19,41M |
| EPS (Diluted) | -2,29 | -3,66 | -1,99 | -5,77 | -3,89 |
| Gross Profit | -59.000,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -170,60M | -192,40M | -84,66M | -31,48M | -18,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 661,81M | 205,90M | 251,64M | 114,44M | 11,13M |
| Total Liabilities | 15,11M | 14,65M | 10,48M | 166,71M | 34,05M |
| Shareholders' Equity | 646,69M | 191,26M | 241,15M | -52,27M | -22,93M |
| Total Debt | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Cash & Equivalents | 172,92M | 114,09M | 49,30M | 87,70M | 10,61M |
| Current Assets | 661,39M | 205,35M | 249,10M | 112,81M | 11,12M |
| Current Liabilities | 15,11M | 14,65M | 10,48M | 8,07M | 5,05M |